Risk of Oral Tongue Cancer Among Immunocompromised Transplant Recipients and Human Immunodeficiency Virus-Infected Individuals in the United States

被引:12
|
作者
Tota, Joseph E. [1 ]
Engels, Eric A. [1 ]
Madeleine, Margaret M. [2 ]
Clarke, Christina A. [3 ]
Lynch, Charles F. [4 ]
Ortiz, Ana P. [5 ]
Hernandez, Brenda Y. [6 ]
Chaturvedi, Anil K. [1 ]
机构
[1] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA
[2] Fred Hutchinson Canc Res Ctr, Dept Epidemiol, 1124 Columbia St, Seattle, WA 98104 USA
[3] Canc Prevent Inst Calif, Fremont, CA USA
[4] Univ Iowa, Dept Epidemiol, Iowa City, IA USA
[5] Univ Puerto Rico, Ctr Comprehens Canc, Canc Control & Populat Sci Program, San Juan, PR 00936 USA
[6] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA
关键词
epidemiology; human immunodeficiency virus (HIV); oral tongue cancer; risk assessment; transplantation recipients; SQUAMOUS-CELL CARCINOMAS; HUMAN-PAPILLOMAVIRUS; CIGARETTE-SMOKING; TRENDS; PEOPLE; CAVITY; HIV; PREVALENCE; DRINKING;
D O I
10.1002/cncr.31359
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Oral tongue cancer incidence has increased among whites in the United States; however, the cause remains unknown. If an infectious agent is implicated, then elevated risk would be expected among immunosuppressed individuals. METHODS: By using population-based registry linkage information from the US Transplant Cancer Match and human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) Cancer Match studies, the authors examined the risk of oral tongue squamous cell carcinoma (SCC) among immunocompromised transplantation recipients and HIV-infected individuals. In addition, the risks of oropharyngeal SCC (strongly related to human papillomavirus infection; modestly affected by immunosuppression), other tobacco/alcohol-related oral cavity SCCs (not thought to be infection/immunosuppression-related), and non-Hodgkin lymphoma of oral cavity/pharynx (strongly related to Epstein-Barr virus; profoundly affected by immunosuppression) were evaluated. RESULTS: Compared with the general population, the risk of non-Hodgkin lymphoma was strongly increased (standardized incidence ratio [SIR]> 8.0). The risk of all SCCs was modestly and similarly elevated among transplantation recipients (SIR range, 2.2-2.7; P-heterogeneity=5.2); whereas, among HIV-infected individuals, the risk of oral tongue SCC was higher compared with the risk of other SCCs (SIR, 3.0 vs 1.7 [for oropharyngeal SCCs] and 2.3 [for other oral cavity SCCs]; P-heterogeneity<.001). The risk of SCCs was significantly higher among men, older individuals, and whites; and risk increased with the time since transplantation/AIDS onset. The risk of oral tongue SCC was significantly higher among HIV-infected men who have sex with men compared with the average risk in HIV-infected individuals (adjusted incidence rate ratio=52.0). CONCLUSIONS: Similar modest increases in the risk of oral tongue and other oral cavity SCCs do not suggest that an infectious agent or exposure profoundly affected by immunosuppression underlies the increase in oral tongue cancer. (C) 2018 American Cancer Society.
引用
收藏
页码:2515 / 2522
页数:8
相关论文
共 50 条
  • [1] Types of Myocardial Infarction Among Human Immunodeficiency Virus-Infected Individuals in the United States
    Crane, Heidi M.
    Paramsothy, Pathmaja
    Drozd, Daniel R.
    Nance, Robin M.
    Delaney, J. A. Chris
    Heckbert, Susan R.
    Budoff, Matthew J.
    Burkholder, Greer A.
    Willig, James H.
    Mugavero, Michael J.
    Mathews, William C.
    Crane, Paul K.
    Moore, Richard D.
    Eron, Joseph J.
    Napravnik, Sonia
    Hunt, Peter W.
    Geng, Elvin
    Hsue, Priscilla
    Rodriguez, Carla
    Peter, Inga
    Barnes, Greg S.
    McReynolds, Justin
    Lober, William B.
    Crothers, Kristina
    Feinstein, Matthew J.
    Grunfeld, Carl
    Saag, Michael S.
    Kitahata, Mari M.
    JAMA CARDIOLOGY, 2017, 2 (03) : 260 - 267
  • [2] Survival of human immunodeficiency virus-infected liver transplant recipients
    Ragni, MV
    Belle, SH
    Im, K
    Neff, G
    Roland, M
    Stock, P
    Heaton, N
    Humar, A
    Fung, JF
    JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (10): : 1412 - 1420
  • [3] CYCLOSPORINE-A TREATMENT FOR HUMAN IMMUNODEFICIENCY VIRUS-INFECTED TRANSPLANT RECIPIENTS
    KLATZMANN, D
    LAPORTE, JP
    ACHOUR, A
    BRISSON, E
    GRUEST, J
    MONTAGNIER, L
    GLUCKMAN, JC
    TRANSPLANTATION PROCEEDINGS, 1987, 19 (01) : 1828 - 1828
  • [4] Cancer risk in people infected with human immunodeficiency virus in the United States
    Engels, Eric A.
    Biggar, Robert J.
    Hall, H. Irene
    Cross, Helene
    Crutchfield, Allison
    Finch, Jack L.
    Griggs, Rebecca
    Hylton, Tara
    Pawlish, Karen S.
    McNeel, Timothy S.
    Goedert, James J.
    INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (01) : 187 - 194
  • [5] Increased risk of histologically defined cancer subtypes in human immunodeficiency virus-infected individuals
    Shiels, Meredith S.
    Engels, Eric A.
    CANCER, 2012, 118 (19) : 4869 - 4876
  • [6] Cardiovascular disease burden among human immunodeficiency virus-infected individuals
    Demir, Ozan M.
    Candilio, Luciano
    Fuster, Daniel
    Muga, Robert
    Barbaro, Giuseppe
    Colombo, Antonio
    Azzalini, Lorenzo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 265 : 195 - 203
  • [7] Influence of immune activation on the risk of allograft rejection in human immunodeficiency virus-infected kidney transplant recipients
    Lorio, Marco A.
    Rosa, Rossana
    Suarez, Jose F.
    Ruiz, Phillip
    Ciancio, Gaetano
    Burke, George W.
    Camargo, Jose F.
    TRANSPLANT IMMUNOLOGY, 2016, 38 : 40 - 43
  • [8] Development of oral lesions in human immunodeficiency virus-infected transfusion recipients and hemophiliacs
    Hilton, JF
    Donegan, E
    Katz, MH
    Canchola, AJ
    Fusaro, RE
    Greenspan, D
    Greenspan, JS
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1997, 145 (02) : 164 - 174
  • [9] Malignancy in perinatally human immunodeficiency virus-infected children in the United States
    Kest, H
    Brogly, S
    McSherry, G
    Dashefsky, B
    Oleske, J
    Seage, GR
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (03) : 237 - 242
  • [10] Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States
    Bing, EG
    Burnam, A
    Longshore, D
    Fleishman, JA
    Sherbourne, CD
    London, AS
    Turner, BJ
    Eggan, F
    Beckman, R
    Vitiello, B
    Morton, SC
    Orlando, M
    Bozzette, SA
    Ortiz-Barron, L
    Shapiro, M
    ARCHIVES OF GENERAL PSYCHIATRY, 2001, 58 (08) : 721 - 728